Both the definition and therapy of advanced prostate cancer is challenging.
The advanced prostate cancer session at "The 8th International Prostate Ca
ncer Update" had discussions which tried to answer the questions of managem
ent of these patients who either present with advanced disease or fail any
form of therapy for clinically confined prostate cancer. This article provi
des an overview of therapeutic options: monotherapy and minimal androgen bl
ockade options versus maximal androgen blockade, adjuvant therapy, intermit
tent therapy and timing of therapy as well as chemotherapy when all these m
easures fail. The impact of these therapies on progression as well as quali
ty of life is reviewed.